The COVID-19 Vaccine Patent Waiver: The Wrong Tool for the Right Goal
Should a waiver be issued, there is no legal mechanism that can compel the transfer of certain types of know-how or trade secrets.

Should a waiver be issued, there is no legal mechanism that can compel the transfer of certain types of know-how or trade secrets.
The vaccine shortage might have less to do with intellectual property, and more to do with financial incentives.